cancer: Microarray data set for breast cancer

Description Format References

Description

This gene expression data set is freely available, coming from the Hess et al's paper. It concerns one hundred thirty-three patients with stage I–III breast cancer. Patients were treated with chemotherapy prior to surgery. Patient response to the treatment can be classified as either a pathologic complete response (pCR) or residual disease (not-pCR). Hess et al developed and tested a reliable multigene predictor for treatment response on this data set, composed by a set of 26 genes having a high predictive value.

Format

Two objects expr (a 26 by 133 matrix with expression levels) and conditions a vector of conditions for the 26 patients.

References

K.R. Hess, K. Anderson, W.F. Symmans, V. Valero, N. Ibrahim, J.A. Mejia, D. Booser, R.L. Theriault, U. Buzdar, P.J. Dempsey, R. Rouzier, N. Sneige, J.S. Ross, T. Vidaurre, H.L. Gomez, G.N. Hortobagyi, and L. Pustzai (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in breast cancer, Journal of Clinical Oncology, vol. 24(26), pp. 4236–4244.


tuxette/internet3D documentation built on May 8, 2019, 11:59 p.m.